Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression

Biochemical and Biophysical Research Communications

Volumn 420, Issue 2, 2012, Pages 428-433

  Lee, Jin Wook ^a   Kim, Geun Young ^a,b   Kim, Jae Hong ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

AR; BLT2; Prostate cancer; ROS; Survival

Indexed keywords

ANDROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE B4 RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE, TUMOR; DISEASE PROGRESSION; HUMANS; MALE; NADPH OXIDASE; NF-KAPPA B; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RECEPTORS, ANDROGEN; RECEPTORS, LEUKOTRIENE B4;

EID: 84862793197     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.012     Document Type: Article

References (32)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
2. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 2001, 1:34-45.
3. Cohen M.B., Rokhlin O.W. Mechanisms of prostate cancer cell survival after inhibition of AR expression. J. Cell Biochem. 2009, 106:363-371.
4. Bhuiyan M.M., Li Y., Banerjee S., Ahmed F., Wang Z., Ali S., Sarkar F.H. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res. 2006, 66:10064-10072.
5. Cheng H., Snoek R., Ghaidi F., Cox M.E., Rennie P.S. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res. 2006, 66:10613-10620.
6. Liao X., Tang S., Thrasher J.B., Griebling T.L., Li B. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol. Cancer Ther. 2005, 4:505-515.
7. Nie D., Che M., Grignon D., Tang K., Honn K.V. Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev. 2001, 20:195-206.
8. Larre S., Tran N., Fan C., Hamadeh H., Champigneulles J., Azzouzi R., Cussenot O., Mangin P., Olivier J.L. PGE2 and LTB4 tissue levels in benign and cancerous prostates. Prostaglandins Other Lipid Mediat. 2008, 87:14-19.
9. McCabe N.P., Selman S.H., Jankun J. Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase. Prostate 2006, 66:779-787.
10. Nie D., Nemeth J., Qiao Y., Zacharek A., Li L., Hanna K., Tang K., Hillman G.G., Cher M.L., Grignon D.J., Honn K.V. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin. Exp. Metastasis 2003, 20:657-663.
11. Ghosh J. Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase. Biochem. Biophys. Res. Commun. 2003, 307:342-349.
12. Pidgeon G.P., Kandouz M., Meram A., Honn K.V. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res. 2002, 62:2721-2727.
13. Tager A.M., Luster A.D. BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot Essent Fatty Acids 2003, 69:123-134.
14. Rocconi R.P., Kirby T.O., Seitz R.S., Beck R., Straughn J.M., Alvarez R.D., Huh W.K. Lipoxygenase pathway receptor expression in ovarian cancer. Reprod. Sci. 2008, 15:321-326.
15. Yoo M.H., Song H., Woo C.H., Kim H., Kim J.H. Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene 2004, 23:9259-9268.
16. Hennig R., Osman T., Esposito I., Giese N., Rao S.M., Ding X.Z., Tong W.G., Buchler M.W., Yokomizo T., Friess H., Adrian T.E. BLT2 is expressed in PanINs IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br. J. Cancer 2008, 99:1064-1073.
17. Choi J.A., Lee J.W., Kim H., Kim E.Y., Seo J.M., Ko J., Kim J.H. Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway. Carcinogenesis 2010, 31:543-551.
18. Seo J.M., Cho K.J., Kim E.Y., Choi M.H., Chung B.C., Kim J.H. Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Exp. Mol. Med. 2011, 43:129-137.
19. Zhang L., Altuwaijri S., Deng F., Chen L., Lal P., Bhanot U.K., Korets R., Wenske S., Lilja H.G., Chang C., Scher H.I., Gerald W.L. NF-kappaB regulates androgen receptor expression and prostate cancer growth. Am. J. Pathol. 2009, 175:489-499.
20. Iizuka Y., Yokomizo T., Terawaki K., Komine M., Tamaki K., Shimizu T. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J. Biol. Chem. 2005, 280:24816-24823.
21. Sharifi N., Hurt E.M., Thomas S.B., Farrar W.L. Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. Clin. Cancer Res. 2008, 14:6073-6080.
22. Choi J.A., Kim E.Y., Song H., Kim C., Kim J.H. Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells. Free Radic. Biol. Med. 2008, 44:624-634.
23. Kim G.Y., Lee J.W., Ryu H.C., Wei J.D., Seong C.M., Kim J.H. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. J. Immunol. 2010, 184:3946-3954.
24. Kim E.Y., Seo J.M., Cho K.J., Kim J.H. Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway. Oncogene 2010, 29:1167-1178.
25. Kim E.Y., Seo J.M., Kim C., Lee J.E., Lee K.M., Kim J.H. BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway. Free Radic. Biol. Med. 2010, 49:1072-1081.
26. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
27. Edwards J., Krishna N.S., Grigor K.M., Bartlett J.M. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br. J. Cancer 2003, 89:552-556.
28. Seaton A., Scullin P., Maxwell P.J., Wilson C., Pettigrew J., Gallagher R., O'Sullivan J.M., Johnston P.G., Waugh D.J. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Carcinogenesis 2008, 29:1148-1156.
29. Hoshino K., Ishiguro H., Teranishi J., Yoshida S., Umemura S., Kubota Y., Uemura H. Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells. Prostate 2011, 71:964-975.
30. Guo Y., Zhang W., Giroux C., Cai Y., Ekambaram P., Dilly A.K., Hsu A., Zhou S., Maddipati K.R., Liu J., Joshi S., Tucker S.C., Lee M.J., Honn K.V. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J. Biol. Chem. 2011, 286:33832-33840.
31. Kumar B., Koul S., Khandrika L., Meacham R.B., Koul H.K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008, 68:1777-1785.
32. Lim S.D., Sun C., Lambeth J.D., Marshall F., Amin M., Chung L., Petros J.A., Arnold R.S. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 2005, 62:200-207.